FibroGen

FGEN-Q

Analysis and Opinions about FGEN-Q

Signal
Opinion
Expert
COMMENT
COMMENT
November 2, 2020
A totally speculative play, so earnings don't matter. They report Wednesday. They're testing an anemia drug in phase 3 now.
Show full opinionHide full opinion
FibroGen (FGEN-Q)
November 2, 2020
A totally speculative play, so earnings don't matter. They report Wednesday. They're testing an anemia drug in phase 3 now.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

FibroGen(FGEN-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for FibroGen is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

FibroGen(FGEN-Q) Frequently Asked Questions

What is FibroGen stock symbol?

FibroGen is a American stock, trading under the symbol FGEN-Q on the NASDAQ (FGEN). It is usually referred to as NASDAQ:FGEN or FGEN-Q

Is FibroGen a buy or a sell?

In the last year, there was no coverage of FibroGen published on Stockchase.

Is FibroGen a good investment or a top pick?

FibroGen was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for FibroGen.

Why is FibroGen stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is FibroGen worth watching?

In the last year 0 stock analysts on Stockchase covered FibroGen. The stock is worth watching.

What is FibroGen stock price?

On 2020-11-25, FibroGen (FGEN-Q) stock closed at a price of $40.02.